Publicacións nas que colabora con Santiago Tomé Martínez de Rituerto (20)
2022
-
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
2021
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
2015
2014
-
Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol
Transplantation Proceedings
-
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study
Journal of Hepatology, Vol. 61, Núm. 5, pp. 1020-1028
2013
-
A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: A randomised controlled study
Anaesthesia and Intensive Care, Vol. 41, Núm. 6, pp. 719-727
2012
2010
-
Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction
Transplantation Proceedings, Vol. 42, Núm. 2, pp. 656-659
2009
-
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction
Liver Transplantation, Vol. 15, Núm. 12, pp. 1792-1797
-
Safety of an Immunosuppressant Protocol Based on Sirolimus in Liver Transplant Recipients With Malignancies or High Risk of Tumor Recurrence
Transplantation Proceedings, Vol. 41, Núm. 3, pp. 1003-1004
2008
-
Orthotopic Liver Transplantation for Hepatocellular Carcinoma: A Thirteen-Year Single-Center Experience
Transplantation Proceedings, Vol. 40, Núm. 9, pp. 2975-2977
2005
-
Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation
Transplantation Proceedings
-
Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients
Transplantation Proceedings
-
Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates
Transplantation Proceedings
2003
-
Utility of ambulatory blood pressure monitoring for diagnosis of hypertension in liver allograft recipients
Transplantation Proceedings
2002
-
Alternative immunosuppression for acute renal failure in liver transplantation: Role of ultra-low dose tacrolimus and basiliximab
Transplantation Proceedings
-
Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation
Hepato-Gastroenterology, Vol. 49, Núm. 43, pp. 249-251
-
Cardiovascular risk factors in liver allograft recipients: Relationship with immunosuppressive therapy
Transplantation Proceedings